Changmao Biochemical Engineering Company Limited (HKG:0954)

HKG:0954 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	36.8	68.15	57.96	89.55	59.99	58.63
Short-Term Investments	2.72	3.65	16.6	7	3.64	-
Cash & Short-Term Investments	39.52	71.8	74.57	96.56	63.63	58.63
Cash Growth	-40.54%	-3.71%	-22.78%	51.75%	8.53%	-56.36%
Accounts Receivable	64.81	75.49	63	87.94	75.42	87.84
Other Receivables	9.61	6.2	11.41	13.87	42.15	27.38
Receivables	74.43	81.69	74.41	101.8	117.57	115.22
Inventory	116.69	110.36	143.35	132.08	160.91	122.9
Prepaid Expenses	-	7.21	5.35	6.27	-	-
Restricted Cash	-	-	1.11	1.61	12.34	14.75
Other Current Assets	-	-	0.01	-	7.59	5.53
Total Current Assets	230.64	271.05	298.79	338.32	362.05	317.03
Property, Plant & Equipment	882.82	886.36	924.98	865.86	773.42	597.56
Other Intangible Assets	0.28	0.37	0.51	0.64	0.77	1.02
Long-Term Deferred Tax Assets	0.35	-	0.22	0.68	24.65	20.49
Other Long-Term Assets	22.53	21.94	25.26	37	45.86	20.42
Total Assets	1,137	1,180	1,250	1,242	1,207	956.52

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	32.74	25.99	28.7	30.77	66.54	95.81
Accrued Expenses	-	6.52	5.96	10.89	21.04	8.38
Short-Term Debt	169.67	207.57	282.63	54.65	103.9	78.4
Current Portion of Long-Term Debt	222.28	220.08	232.11	187.55	33.64	8.5
Current Portion of Leases	44.39	50.89	0.68	0.96	0.68	0.58
Current Income Taxes Payable	-	1.57	1.54	2.16	3.31	6.4
Current Unearned Revenue	50.25	4.99	7.52	5.16	6.28	8.36
Other Current Liabilities	-	29.89	45.42	33.09	38.63	50.3
Total Current Liabilities	519.34	547.49	604.55	325.24	274.02	256.71
Long-Term Debt	52.41	60.32	20.3	250.41	152.07	1.5
Long-Term Leases	-	0.22	0.42	1.07	1.21	0.27
Long-Term Unearned Revenue	53.15	54.78	40.47	13.58	0.04	0.06
Long-Term Deferred Tax Liabilities	0.64	0.74	0.68	0.6	0.53	0.45
Total Liabilities	625.54	663.56	666.42	590.91	427.86	258.99

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	52.97	52.97	52.97	52.97	52.97	52.97
Additional Paid-In Capital	-	102.56	102.56	102.56	102.56	102.56
Retained Earnings	266.95	358.75	426.29	494.65	622.54	541.11
Comprehensive Income & Other	191.83	2.41	1.63	1.51	0.47	0.46
Total Common Equity	511.75	516.68	583.45	651.69	778.53	697.1
Minority Interest	-0.68	-0.51	-0.11	-0.1	0.36	0.43
Shareholders' Equity	511.07	516.17	583.34	651.59	778.89	697.53
Total Liabilities & Equity	1,137	1,180	1,250	1,242	1,207	956.52

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	488.76	539.07	536.13	494.65	291.5	89.26
Net Cash (Debt)	-449.24	-467.27	-461.57	-398.09	-227.87	-30.63
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.85	-0.88	-0.87	-0.75	-0.43	-0.06
Filing Date Shares Outstanding	529.7	529.7	529.7	529.7	529.7	529.7
Total Common Shares Outstanding	529.7	529.7	529.7	529.7	529.7	529.7
Working Capital	-288.7	-276.44	-305.76	13.08	88.03	60.31
Book Value Per Share	0.97	0.98	1.10	1.23	1.47	1.32
Tangible Book Value	511.47	516.31	582.94	651.05	777.76	696.08
Tangible Book Value Per Share	0.97	0.97	1.10	1.23	1.47	1.31
Buildings	-	461.06	401.76	289.52	273.77	210.9
Machinery	-	730.67	640.92	543.86	482.6	399.21
Construction In Progress	-	90.68	230.34	339.05	250.54	211.16

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 24, 2026

Data Sources Report a data error